# Clinical Trials Started in 2025 - Analysis Summary

**Data Source:** ClinicalTrials.gov  
**Analysis Date:** January 23, 2026  
**Total Trials:** 36,586

---

## üìä Key Findings

### Overall Statistics
- **Total Clinical Trials:** 36,586 trials started in 2025
- **Peak Month:** September 2025 (3,599 trials)
- **Lowest Month:** November 2025 (2,140 trials)
- **Average per Month:** 3,049 trials

---

## üè• Top 10 Therapeutic Areas

| Rank | Therapeutic Area | Trials | Percentage |
|------|------------------|--------|------------|
| 1 | **Oncology** | 6,701 | 18.3% |
| 2 | **Cardiovascular** | 2,867 | 7.8% |
| 3 | **Diabetes/Metabolic** | 1,807 | 4.9% |
| 4 | **Neurological** | 1,659 | 4.5% |
| 5 | **Pain Management** | 1,479 | 4.0% |
| 6 | **Psychiatry/Mental Health** | 1,202 | 3.3% |
| 7 | **Infectious Disease** | 1,184 | 3.2% |
| 8 | **Immunology/Rheumatology** | 1,127 | 3.1% |
| 9 | **Respiratory** | 1,030 | 2.8% |
| 10 | **Gastroenterology** | 598 | 1.6% |

**Note:** "Other" category accounts for 12,900 trials (35.3%) representing miscellaneous therapeutic areas.

---

## üìÖ Monthly Breakdown (All Trials)

| Month | Total Trials | Top Therapeutic Area |
|-------|--------------|---------------------|
| **January** | 3,586 | Oncology (563) |
| **February** | 2,899 | Oncology (481) |
| **March** | 3,412 | Oncology (587) |
| **April** | 3,079 | Oncology (549) |
| **May** | 3,014 | Oncology (575) |
| **June** | 3,083 | Oncology (577) |
| **July** | 2,986 | Oncology (584) |
| **August** | 2,757 | Oncology (528) |
| **September** | 3,599 | Oncology (654) |
| **October** | 2,685 | Oncology (515) |
| **November** | 2,140 | Oncology (396) |
| **December** | 3,346 | Oncology (692) |

---

## üìà Quarterly Trends

### Q1 2025 (January - March)
- **Total:** 9,897 trials
- **Top Area:** Oncology (1,631 trials)
- **Trend:** Strong start to the year

### Q2 2025 (April - June)
- **Total:** 9,176 trials
- **Top Area:** Oncology (1,701 trials)
- **Trend:** Slight decline from Q1

### Q3 2025 (July - September)
- **Total:** 9,342 trials
- **Top Area:** Oncology (1,766 trials)
- **Trend:** Recovery with September peak

### Q4 2025 (October - December)
- **Total:** 8,171 trials
- **Top Area:** Oncology (1,603 trials)
- **Trend:** Decline, especially in November

---

## üîç Insights & Observations

### 1. **Oncology Dominance**
Oncology consistently leads across all months, representing nearly 1 in 5 trials. This reflects:
- Continued focus on cancer research
- Diverse cancer types and treatment modalities
- Strong pharmaceutical industry investment

### 2. **Seasonal Patterns**
- **Peak Activity:** September (3,599 trials)
- **Low Activity:** November (2,140 trials)
- Possible factors: Fiscal year cycles, conference timing, holiday periods

### 3. **Cardiovascular & Metabolic Health**
Combined Cardiovascular (2,867) and Diabetes/Metabolic (1,807) trials represent 4,674 trials (12.8%), highlighting focus on:
- Chronic disease management
- Prevention strategies
- Novel therapeutics

### 4. **Mental Health Focus**
Psychiatry/Mental Health (1,202 trials, 3.3%) shows significant attention to:
- Depression and anxiety disorders
- Post-pandemic mental health crisis
- Digital therapeutics

### 5. **Infectious Disease Research**
1,184 trials (3.2%) in Infectious Disease indicates ongoing focus on:
- COVID-19 variants and long COVID
- Antimicrobial resistance
- Vaccine development

---

## üìÅ Generated Files

1. **Data File:** `clinical_trials_2025.json`
   - Complete structured data with monthly breakdowns
   - All 24 therapeutic areas categorized

2. **Grouped Bar Chart:** `clinical_trials_2025_chart.html`
   - Interactive visualization
   - Top 10 therapeutic areas by month
   - Hover for detailed information

3. **Stacked Bar Chart:** `clinical_trials_2025_stacked_chart.html`
   - Shows total monthly composition
   - Top 12 therapeutic areas
   - Easy comparison of monthly trends

---

## üéØ Key Takeaways

1. **Volume:** 2025 saw robust clinical trial activity with 36,586+ new trials
2. **Focus Areas:** Cancer, heart disease, and metabolic disorders remain priorities
3. **Innovation:** Diverse therapeutic areas beyond top 10 represent 35% of trials
4. **Global Health:** Continued emphasis on infectious disease and mental health
5. **Consistency:** Oncology maintains leadership across all 12 months

---

## üìä Data Quality Notes

- Source: ClinicalTrials.gov official API (v2)
- Extraction Method: Complete dataset download and categorization
- Therapeutic Area Assignment: Based on primary condition/disease field
- Category Logic: AI-powered classification into 24 therapeutic areas
- Date Filter: Study start date between January 1, 2025 and December 31, 2025

---

**Analysis completed:** January 23, 2026  
**Data current as of:** ClinicalTrials.gov database snapshot
